I recall AMBS having around a $150 million market cap

New Post Public Reply Private Reply Replies (1) Message Board
jamiejaytrader Orioles1 #24586
475
I recall AMBS having around a $150 million market cap (before the reverse split and without ESS).

Now we have a stronger pipeline (ESS was bought) and we will get an additional 4 assests with the planned deal.
And we are currently sitting around a $4 million market cap.
Talk about greatly undervalued! (are market cap would suggest you would go bankrupt imo) the pps/market cap is not reflecting reality!

So yeah, we definitely have A LOT of room to grow with the pps! i agree

I'd say we are at least worth a $100 million with our assets (not even including those 4 additional assest, no idea how much that will be worth and if it produces revenues already, i haven't checked that yet).

I recall Gerald saying ESS was currently worth $50 million or was it a $100 million?

I also recall him saying in an interview that we have a potential of $8 billion market potential (that is of course if everything would work out oké with the assets!).

But the only thing is, is that we don't know how much outstanding shares are on the market right now. Last time they reported i recalled 67 or 68 million outstanding shares but that was more then 7 months back or so.

So lets say we are at $100 million outstanding shares right now (maybe even more!). Fair value would be at least $1 imo (not including those 4 future additional assets).

We are currently sitting at $0.065!!!! thats a lot of room to grow!

Now when they close the deal, i'm sure other deals for our assets (ESS, MANF, ELTO) might be closed soon after or simultaneously with our SeD partner. That also brings more value to our company.

Imagine they announce a funding partner for ESS right after they announce they cleaned up the balance and removed those pesky toxics.

Who know's where we will open up to when a deal is completed and announced.

I'm speculating right now but i'm guessing we will be between $0.50 and $1.00 after an announcement is made.

Assuming everything goes according to plan.
But hey.... they already have two new directors for AMBS so i'm pretty confident they are moving ahead with the plan.

Anyone else wants to share their thoughts?

GL everyone! things are finally looking up for us after such a long wait!

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

The Future of Pharmaceutical Contract Packaging: Growth Insights

Updated Category News Views 74

Overview of the Pharmaceutical Contract Packaging Market The global market for pharmaceutical contract packaging is set to experience notable growth, propelled by advances in technology and increased investment in research and development. Estimates indicate a remarkable increase of USD 9.32 billion from 2024 to 2028, equating to a compound annual growth rate (CAGR) of...

Continue Reading
Palantir's CTO Highlights US Deterrence Challenges Ahead

Updated Category News Views 209

Palantir's CTO Discusses National Security Challenges Shyam Sankar, the Chief Technology Officer of the innovative data analytics and cybersecurity company Palantir Technologies Inc. (NASDAQ: PLTR), recently expressed serious concerns regarding America's fading deterrence capacity. While appearing on the New York Times podcast, he made it clear that the nation is no...

Continue Reading
Concerns Rise for Long-Term Investors of Super Micro Computer

Updated Category News Views 211

Investigation Launch: A Call to Action for Shareholders Bragar Eagel & Squire, P.C., a highly regarded law firm focused on shareholder rights, is launching an investigation into potential claims against Super Micro Computer, Inc. (NASDAQ: SMCI). This examination primarily targets the company’s conduct leading up to a class action lawsuit filed against it. The firm is...

Continue Reading
Children’s Place Reports Significant Results and Strategies Ahead

Updated Category News Views 283

Strong Performance in the Fourth Quarter The Children’s Place, Inc. (Nasdaq: PLCE), recognized as North America's leading children's specialty retailer, has reported remarkable progress in its financial performance for the fourth quarter. The company achieved net sales totaling $409 million for this quarter, along with a total of $1.386 billion for the entire fiscal...

Continue Reading
The Incredible Growth of Extra Space Storage Over Time

Updated Category News Views 391

Understanding Extra Space Storage's Historical Returns Extra Space Storage (NYSE: EXR) has significantly outperformed the market during the past 15 years, registering an impressive annualized return of 16.14%. This performance is not just a statistic; it represents a compound growth that can transform an initial investment. The Power of Compound Returns To illustrate...

Continue Reading